Gracell Biotechnologies Analysis
Gracell Biotechnologies is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Gracell Biotechnologies delisted stock analysis is to determine its intrinsic value, which is an estimate of what Gracell Biotechnologies is worth, separate from its market price. There are two main types of Gracell Biotechnologies' stock analysis: fundamental analysis and technical analysis.
The Gracell Biotechnologies stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Gracell |
Gracell Stock Analysis Notes
About 16.0% of the company shares are held by company insiders. The book value of Gracell Biotechnologies was currently reported as 16.9. The company recorded a loss per share of 0.97. Gracell Biotechnologies had not issued any dividends in recent years. Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the Peoples Republic of China. The company was founded in 2017 and is headquartered in Suzhou, China. Gracell Biotechnologies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 348 people. To learn more about Gracell Biotechnologies call the company at 86 512 6262 6701 or check out https://www.gracellbio.com.Gracell Biotechnologies Investment Alerts
| Gracell Biotechnologies is not yet fully synchronised with the market data | |
| Gracell Biotechnologies has some characteristics of a very speculative penny stock | |
| Gracell Biotechnologies has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (496.98 M) with profit before overhead, payroll, taxes, and interest of 366 K. | |
| Gracell Biotechnologies currently holds about 1.71 B in cash with (482.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 25.28. | |
| Roughly 63.0% of the company shares are owned by institutional investors |
Gracell Biotechnologies Upcoming and Recent Events
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 11th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Gracell Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 989.87 M.Gracell Biotechnologies Outstanding Bonds
Gracell Biotechnologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Gracell Biotechnologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Gracell bonds can be classified according to their maturity, which is the date when Gracell Biotechnologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Gracell Biotechnologies to your portfolios without increasing risk or reducing expected return.Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
| All Next | Launch Module |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Gracell Stock
If you are still planning to invest in Gracell Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gracell Biotechnologies' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |